24-Apr-2024
No headlines found.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TARO, HES, ANSS
PRNewswire (Tue, 23-Apr 1:03 PM ET)
Business Wire (Mon, 22-Apr 4:06 PM ET)
Business Wire (Mon, 15-Apr 8:00 AM ET)
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates TAST, TARO, MDC
Globe Newswire (Sat, 10-Feb 10:44 AM ET)
INVESTIGATION ALERT: Halper Sadeh LLC Investigates HARP, TARO, FFNW
Globe Newswire (Tue, 6-Feb 9:13 PM ET)
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates PGTI, TARO, ANSS
Globe Newswire (Tue, 30-Jan 1:41 PM ET)
Kuehn Law Encourages PGTI, TAST, TARO, and ANSS Investors to Contact Law Firm
PRNewswire (Tue, 30-Jan 1:18 PM ET)
Krensavage Asset Management Remains Opposed to Sun's Predatory Bid for Taro
PRNewswire (Tue, 30-Jan 7:00 AM ET)
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ANSS, TARO, MDC
PRNewswire (Mon, 29-Jan 11:01 PM ET)
Taro Provides Results for December 31, 2023
Business Wire (Thu, 25-Jan 5:06 PM ET)
Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.
Taro Pharmaceutical Industries Ltd. trades on the NYSE stock market under the symbol TARO.
As of April 24, 2024, TARO stock price declined to $42.20 with 19,062 million shares trading.
TARO has a beta of 1.08, meaning it tends to be more sensitive to market movements. TARO has a correlation of 0.14 to the broad based SPY ETF.
TARO has a market cap of $1.59 billion. This is considered a Small Cap stock.
Last quarter Taro Pharmaceutical Industries Ltd. reported $157 million in Revenue and $.56 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.26.
In the last 3 years, TARO stock traded as high as $76.46 and as low as $22.89.
The top ETF exchange traded funds that TARO belongs to (by Net Assets): IWM, IWN, IEFA, IZRL, DFAC.
TARO has outperformed the market in the last year with a price return of +71.5% while the SPY ETF gained +24.2%. However, in the short term, TARO had mixed performance relative to the market. It has underperformed in the last 3 months, returning +0.3% vs +4.6% return in SPY. But in the last 2 weeks, TARO shares have fared better than the market returning 0.0% compared to SPY -2.7%.
TARO support price is $42.01 and resistance is $42.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TARO stock will trade within this expected range on the day.